KRT5 and neoplasm: However, our findings from GK and EPI cells show that this down-regulation of CDH1 caused by KRT5 inhibition is not a phenomenon of the final tumor-related cell transformation, i.e., the malignant tumor in vivo, but rather occurs at the beginning of the transformation process, i.e., if the cells are not yet tumorigenic.